Originally posted on Sussex Drug Discovery Group:
This analysis by Asher Mullard published in Nature Reviews Drug Discovery (
2014,13, 85-89)
reports the new drugs approved by FDA in 2013. From a total of thirty-six applications, twenty-five new small molecules and two new biologics were approved. The same trend as the previous years was overall maintained, with the exception of 2012. (Figure 1).

Filed under: Uncategorized
